DJIA 18,214.42 -10.15 -0.06%
NASDAQ 4,987.89 20.75 0.42%
S&P 500 2,110.74 -3.12 -0.15%
market minute promo

Illumina (NASDAQ: ILMN)

198.46 2.24 (1.14%)

REAL-TIME: Last trade at

Extended Hours: $198.00 -$0.46 (-0.23%)
Quote as of (NASDAQ)

company name or ticker

Recent Quotes

ILMN $198.46 1.14%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $196.44
Previous Close $196.22
Daily Range $193.18 - $198.89
52-Week Range $127.69 - $213.33
Market Cap $28.5B
P/E Ratio 82.79
Dividend (Yield) $0.00 (0.0%)
Volume 714,201
Average Daily Volume 1,248,517
Current FY EPS $3.21




Drug Makers

Illumina (ILMN) Description

The Company is a developer, manufacturer and marketer of next-generation life-science tools and integrated systems for the analysis of genetic variation and biological function. Website:

News & Commentary

Could This Disruptive New Technology Lead to a Cure for Cancer?

Major drugmakers are investing heavily in a disruptive technology that could lead to game-changing breakthroughs in the treatment of cancer. Here's what you need to know.

3 Stocks Pushing The Drugs Industry Downward

Illumina Expands NGS Portfolio with NeoPrep Library System - Analyst Blog

Illumina Larger Than S&P 500 Component McGraw Hill Financial

VXF, AAL, ILMN, UAL: ETF Inflow Alert

3 Niche ETFs Breaking Out

Is This Company the Big Winner in Obama's Push for Precision Medicine?

Illumina gene sequencing demand could head higher thanks to President Obama's precision medicine plan.

Pacific Biosciences Is Being Eaten Alive By Illumina

Andreas Halvorsen's Trades Of January 2015

5 Top Credit Suisse Health Care Stock Picks to Buy for 2015

See More ILMN News...

ILMN's Top Competitors

ILMN $198.46 (1.14%)
Current stock: ILMN
TMO $130.14 (-0.71%)
Current stock: TMO
$0.00 (0.00%)
Current stock:
QGEN $24.99 (0.40%)
Current stock: QGEN